Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ORBION PHARMS

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 58
  • 0 comments

FDA approve ARIPIPRAZOLE

Comment Full text

RISING

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 61
  • 0 comments

FDA approve LINEZOLID

Comment Full text

DECIPHERA PHARMS

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 73
  • 0 comments

FDA approve VIMSELTINIB

Comment Full text

IMPAX

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 65
  • 0 comments

FDA approve APIXABAN

Comment Full text

HIKMA

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 69
  • 0 comments

FDA approve NAPROXEN

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 67
  • 0 comments

FDA approve ATROPINE SULFATE

Comment Full text

BAUSCH AND LOMB

  • FDA Approval
  • Feb. 20, 2025, 04:33 UTC
  • 64
  • 0 comments

FDA approve BROMFENAC SODIUM

Comment Full text

ABBVIE

  • FDA Approval
  • Feb. 15, 2025, 06:46 UTC
  • 68
  • 0 comments

FDA approve FLUOROMETHOLONE

Comment Full text

SOMERSET THERAPS LLC

  • FDA Approval
  • Feb. 15, 2025, 06:46 UTC
  • 59
  • 0 comments

FDA approve ACETYLCYSTEINE

Comment Full text

SANOFI-AVENTIS U.S. LLC

  • FDA Approval
  • Feb. 15, 2025, 06:46 UTC
  • 58
  • 0 comments

FDA approve INSULIN ASPART-SZJJ

Comment Full text
  • Previous
  • 237
  • 238
  • 239
  • 240
  • 241
  • Next

Search

News categories

  • Technical Exchange News(12324)
  • Event(6229)
  • SEC News(269571)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(156736)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin